title: A phase II study of doxifluridine in patients with advanced breast cancer.
authors.affiliation: Division d'Onco-Hématologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Alberto
authors.forename: W F
authors.initials: WF
authors.lastname: Jungi
authors.forename: P
authors.initials: P
authors.lastname: Siegenthaler
authors.forename: B
authors.initials: B
authors.lastname: Mermillod
authors.forename: J P
authors.initials: JP
authors.lastname: Obrecht
authors.forename: G
authors.initials: G
authors.lastname: Decoster
authors.forename: F
authors.initials: F
authors.lastname: Cavalli
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged
chemical_list: D000970:Antineoplastic Agents; D005467:Floxuridine; C025034:doxifluridine